June 13, 2011 (Washington, DC) — Data from 64 HeartMate II (Thoratec) left ventricular assist device (LVAD) patients treated at the Henry Ford Hospital in Detroit suggest that many of the patients ...
PLEASANTON, CA — Thoratec has issued a safety advisory that recommends relabeling and patient retraining on a backup accessory for its HeartMate II LVAS, a left ventricular assist device (LVAD), after ...
PLEASANTON, Calif., May 3, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts ...
In the ROADMAP study, patients with a HeartMate II ™ LVAD had a functional improvement in quality of life compared to optimal medical management The ROADMAP study was a prospective, multi-center ...
Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3
ORLANDO, FL—The latest-generation HeartMate left ventricular assist device has beat out its predecessor with results so promising that at least one observer is raising the question of whether it’s ...
NEW YORK (April 25, 2008) -- Heart failure patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first to be implanted with the HeartMate® II LVAS (Left ...
Thoratec shed almost one-third of its value after reporting abysmal second quarter earnings. The advanced heart failure device company attributed most of the miss to a New England Journal of Medicine ...
The HeartMate II is a continuous flow device designed to provide long-term cardiac support for advanced-stage heart failure. "We are delighted with the panel's recommendation indicating their belief ...
Thoratec Corp.THOR recently presented positive data for its HeartMate II heart pump device from the ENDURANCE destination therapy trial at the 35th Annual Meeting and Scientific Sessions of the ...
MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...
March 12 (UPI) --The HeartMate 3, an update to one of the most widely-used left ventricle assist devices, or LVADs, in the world, showed strong long-term results during a large clinical trial, its ...
Abbott LaboratoriesABT recently announced late-breaking results from the MOMENTUM 3 randomized control clinical trial. Data highlighted the favorable outcome of the HeartMate 3 left ventricular assist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback